Beyond the Petri dish: Testing tomorrow's drugs in human blood
The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against the virus. But the list of diseases that can potentially be treated with mRNA-based drugs is much broader than vaccines. mRNA is expected to be used to treat disorders including cardiovascular diseases, rare hereditary diseases and autoimmune diseases—and not least, cancer.
Discover Recifes.net
This story is part of Recifes international coverage. Explore the platform and follow us — new English social channels come next.
Matéria produzida com curadoria editorial assistida por IA, a partir de pauta de
phys.org.
Leia também